Selected article for: "acute respiratory syndrome and lung density"
Author: Rogliani, Paola; Calzetta, Luigino; Coppola, Angelo; Puxeddu, Ermanno; Sergiacomi, Gianluigi; D’Amato, Dejanira; Orlacchio, Antonio
Title: Are there pulmonary sequelae in patients recovering from COVID-19?
  • Cord-id: u9ppj53e
  • Document date: 2020_10_30
    • ID: u9ppj53e
    Snippet: It has been recently hypothesized that infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to fibrotic sequelae in patients recovering from coronavirus disease 2019 (COVID-19). In this observational study, hospitalized patients with COVID-19 had a HRCT of the chest performed to detect the extension of fibrotic abnormalities via Hounsfield Units (HU). At follow-up, the lung density significantly improved in both lungs and in each lobe of all patients, being in the n
    Document: It has been recently hypothesized that infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to fibrotic sequelae in patients recovering from coronavirus disease 2019 (COVID-19). In this observational study, hospitalized patients with COVID-19 had a HRCT of the chest performed to detect the extension of fibrotic abnormalities via Hounsfield Units (HU). At follow-up, the lung density significantly improved in both lungs and in each lobe of all patients, being in the normal range (− 950 to − 700 HU). This study provides preliminary evidence that hospitalized patients with mild-to-moderate forms of COVID-19 are not at risk of developing pulmonary fibrosis.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and admission post day: 1, 2, 3
    • acute ards respiratory distress syndrome and long large: 1
    • acute ards respiratory distress syndrome and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and lung abnormality: 1, 2
    • acute ards respiratory distress syndrome and lung density: 1, 2, 3
    • acute ards respiratory distress syndrome and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung function variable: 1
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and lobar distribution: 1
    • acute lung injury and low molecular: 1, 2, 3, 4
    • acute lung injury and low molecular weight heparin: 1, 2
    • acute lung injury and lung abnormality: 1
    • acute lung injury and lung density: 1, 2, 3
    • acute lung injury and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and lung function variable: 1
    • acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lobar distribution and lung function: 1
    • lobar distribution and lung injury: 1